Far fewer babies had severe cases of the respiratory illness RSV, in a winter in which a new monoclonal and vaccine became ...

(Reuters) -Infant hospitalizations due to respiratory syncytial virus (RSV) infections in the United States dropped as much ...

A comprehensive new study reveals that respiratory syncytial virus (RSV) vaccines provide strong protection for adults aged 60 and older, with approximately 75% effectiveness against RSV-associated ...

Here's what RSV is, why it especially impacts the youngest and oldest members of society and how it is usually treated.

The nation’s infant mortality rate is falling. Some experts think one reason may be a vaccination campaign against RSV.

A Spanish study found that nirsevimab prophylaxis significantly reduced infant hospitalizations, ICU admissions, and severe ...

In a recent study of a population of infants, published online May 6 in Pediatrics, 72% of infants were found to be immunized ...

For a broader group of infants—0 to 7 months old—RSV-NET showed a 43 percent drop in hospitalizations in the 2024–2025 RSV season, and NVSN saw a 28 percent drop. Again, when Houston was excluded from ...

You’ve worked extensively on respiratory syncytial virus (RSV) and influenza. What are the key differences in how the immune ...

The overall uptake of RSV vaccine is low during its first season in those aged 60 years or older in the United States. The ...

Nirsevimab is effective for reducing the burden of respiratory syncytial virus (RSV) in infants in real-world settings, ...

Saskatchewan is expanding its infant immunization program to protect all newborns from Respiratory Syncytial Virus (RSV) ...